A recent warning letter that focused in part on gut health claims points out the chinks in FDA’s policy facade, as it takes the target firm to task over some claims that seem benign in nature.
NutraIngredients-USA sat down with Aaron Secrist, executive vice president of Quality, Regulatory Affairs & Operations at NOW Health Group, to reflect on what has happened over the past year and what he thinks is next for the e-commerce giant.
Following Probiotas Americas, NutraIngredients-USA sat down with Attorney Ivan Wasserman to hear what is going on in the legal world of dietary supplements.
With the pandemic all but behind us, it’s clear that most retailers won’t be able to rely on their old strategies and business models as we enter the next phase. So what can we expect?
From daily dietary microbe intake recommendations to emerging health endpoints like PCOS and weight management, and understanding the changing retail landscape, the exceptional content at the IPA World Congress + Probiota Americas Digital Summit continues...
Supplementation with a novel bacterium isolated from the human gut may counteract diet-induced obesity, insulin resistance, and inflammation, says a new study that creates “an incredible scientific opportunity”.
Increased diversity of a mother’s gut microbiota during the third trimester of pregnancy may influence a child’s brain development and behavior, says a new study from Australia.
The IPA World Congress + Probiota Americas 2021 is one week away! The leading event for the the probiotics, prebiotics, and microbiome community is a must-attend event, and let us tell you why…
Biotech start-up FitBiomics has launched its first consumer product under the Nella brand, with more to come from the company that is mining the microbiomes of elite athletes for next generation probiotics.
A focus on transparency and direct benefits for the end user may help change the conversation around genetic engineering, says the CEO of the company behind the world’s first ever genetically engineered probiotic.
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2'-fucosyllactose (2'FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.
Powerful tools like artificial intelligence and CRISPR are set to drive next generation solutions to modulate the microbiome: Find out more at the upcoming IPA World Congress + Probiota Americas Digital Summit.
From the potential of artificial intelligence and CRISPR to modulate the microbiome to the science around probiotics and prebiotics and immune function and the changing retail landscape, the upcoming IPA World Congress + Probiota Americas is not to be...
